Yongjun Sui – InmunoES

Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters

7 de February de 2025 by Yongjun Sui

IntroductionMost COVID-19 vaccine trials have focused on recipient protection, not protection of their contacts, a critical need. As a subunit intranasal COVID-19 vaccine reduced nasopharyngeal virus more than did an intramuscular (IM) vaccine, we hypo…

Trained immunity inducers in cancer immunotherapy

16 de July de 2024 by Yongjun Sui

While most of the cancer immunotherapy strategies engage adaptive immunity, especially tumor-associated T cells, the small fraction of responding patients and types of cancers amenable, and the possibility of severe adverse effects limit its usage. Mor…